Related Experiment Videos
Systemic side effects from ophthalmic timolol and their prevention
1Department of Ophthalmology, Oregon Health Sciences University, Portland.
Journal of Ocular Pharmacology
|January 1, 1987
Summary
Topical eye drops like timolol can cause systemic side effects. Proper application and dosage are key to minimizing these risks in glaucoma patients.
Area of Science:
- Ophthalmology
- Pharmacology
- Clinical Medicine
Background:
- Topical ophthalmic medications can lead to systemic absorption.
- Systemic adverse effects are increasingly recognized with ocular drug administration.
- Timolol, a beta-blocker for glaucoma, is associated with significant systemic effects.
Purpose of the Study:
- To highlight the risk of systemic adverse effects from topical ocular timolol.
- To discuss methods for reducing systemic absorption and adverse events.
Main Methods:
- Review of existing evidence on systemic effects of topical ocular drugs.
- Discussion of drug absorption and metabolism pathways.
- Analysis of administration techniques to minimize systemic exposure.
Main Results:
- Topical timolol administration can result in significant systemic adverse effects.
- Systemic absorption and altered drug metabolism contribute to these effects.
- Specific application techniques can reduce drug entry into systemic circulation.
Conclusions:
- Awareness of systemic risks associated with topical ocular timolol is crucial.
- Proper eye drop application and dosage management are essential for patient safety.
- Further research into minimizing systemic drug exposure from ophthalmic formulations is warranted.